Literature DB >> 220704

Angiotensin-converting enzyme. I. Activity and correlation with serum lysozyme in sarcoidosis, other chest or lymph node diseases and healthy persons.

C Grönhagen-Riska.   

Abstract

Serum angiotensin-converting enzyme (ACE) activity was studied in healthy controls, in 57 untreated sarcoidosis patients, and in 164 patients with other chest or lymph node diseases. The serum ACE activity of healthy persons was independent of sex, intake of meals, and smoking habits. There were no diurnal variations. Healthy children had a significantly higher ACE mean value than adults, whose ACE activity was not affected by age. The sarcoidosis patients had the highest ACE mean values, but those of patients with silicosis and asbestosis were also significantly elevated. Pulmonary cancer patients had decreased serum ACE activity, which was probably due to antimitotic treatment. Serum lysozyme (LZM) concentrations did not correlate with normal ACE activity, but the correlation between elevated ACE and LZM was significant in sarcoidosis and silicosis, and the trend was clearly the same for asbestosis. This indicates separate sources for these enzymes when ACE activity is normal, and a common source, i.e. macrophages, when ACE activity is increased. ACE production in certain diseases involving macrophages may be due to the bradykinin inhibiting effect of this enzyme.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 220704

Source DB:  PubMed          Journal:  Scand J Respir Dis        ISSN: 0036-5572


  11 in total

1.  Direct radioimmunoassay of angiotensin-converting enzyme in sera from patients with pulmonary diseases.

Authors:  K Hiwada; Y Inoue; Y Takada; A Hashimoto; H Akutsu; F Kitatani; T Kokubu
Journal:  Lung       Date:  1987       Impact factor: 2.584

2.  Conjunctival biopsy in the diagnosis of sarcoidosis.

Authors:  R F Spaide; D L Ward
Journal:  Br J Ophthalmol       Date:  1990-08       Impact factor: 4.638

Review 3.  Serum angiotensin converting enzyme in pulmonary disease.

Authors:  P K Rohatgi
Journal:  Lung       Date:  1982       Impact factor: 2.584

4.  Changes of s-angiotensin-converting enzyme (SACE) during antituberculous chemotherapy.

Authors:  H Harving; F K Rømer
Journal:  Lung       Date:  1983       Impact factor: 2.584

5.  Lack of correlation between serum angiotensin-converting enzyme levels and asbestosis in man, sheep and guinea-pig.

Authors:  G Forget; C Brault; A Cadieux; R Bégin; P Sirois
Journal:  Lung       Date:  1983       Impact factor: 2.584

6.  Serum angiotensin converting enzyme in pneumonias.

Authors:  Y Kerttula; T H Weber
Journal:  J Clin Pathol       Date:  1986-11       Impact factor: 3.411

7.  Surfactant protein A (SP-A) and angiotensin converting enzyme (ACE) as early biomarkers for pulmonary edema formation in ventilated human lung lobes.

Authors:  Mirjam Gnadt; Boris Kardziev; Michael Schmidt; Petra Högger
Journal:  Lung       Date:  2012-04-01       Impact factor: 2.584

8.  Smoking and pulmonary sarcoidosis: effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease.

Authors:  D Valeyre; P Soler; C Clerici; J Pré; J P Battesti; R Georges; A J Hance
Journal:  Thorax       Date:  1988-07       Impact factor: 9.139

9.  [Angiotensin-converting enzyme activity during cytostatic therapy in patients with primary inoperable bronchial carcinoma].

Authors:  I Heck; N Niederle
Journal:  Klin Wochenschr       Date:  1983-09-15

Review 10.  Angiotensin-converting enzyme and its clinical significance--a review.

Authors:  P R Studdy; R Lapworth; R Bird
Journal:  J Clin Pathol       Date:  1983-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.